Explore

AP News AP News
WHO says Congo's Ebola outbreak started months before it was declared

WHO says Congo's Ebola outbreak started months before it was declared

The World Health Organization says the fastest-growing Ebola outbreak started in February, months before it was officially declared in May
AP News AP News
WHO says Congo's fast-moving Ebola outbreak started months before it was declared

WHO says Congo's fast-moving Ebola outbreak started months before it was declared

The World Health Organization says the fastest-growing Ebola outbreak started in February, months before it was officially declared in May
Rapid Read Rapid Read
Rotary's Global Efforts in Polio Eradication Show Significant Progress

Rotary's Global Efforts in Polio Eradication Show Significant Progress

Rotary International has been a key player in the global fight against polio, launching its first vaccination initiative in the Philippines in 1979 and becoming a founding partner of the Global Polio Eradication Initiative in 1988. Since then, polio cases have decreased by 99.9%, with the disease remaining endemic in only Afghanistan and Pakistan. Rotary's efforts have been instrumental in reducing the spread of polio, particularly in vulnerable regions.
Rapid Read Rapid Read
Ebola Outbreak in DRC Displacement Camps Raises Health Concerns

Ebola Outbreak in DRC Displacement Camps Raises Health Concerns

The Ebola Bundibugyo virus has been detected in displacement camps in the Democratic Republic of Congo (DRC), affecting 19 internally displaced individuals and resulting in five deaths. The outbreak has been reported in five of Ituri province's 69 camps, raising alarms about the virus's spread among vulnerable populations. The World Health Organization (WHO) and UNHCR are collaborating with local authorities to enhance response efforts, including surveillance, treatment, and community engagement. The outbreak poses significant risks due to inadequate water and sanitation infrastructure in the camps.
Rapid Read Rapid Read
Ebola Outbreak in DRC Claims Over 300 Children Amidst Healthcare Disruptions

Ebola Outbreak in DRC Claims Over 300 Children Amidst Healthcare Disruptions

The Ebola outbreak in the Democratic Republic of Congo (DRC) has resulted in the deaths of over 300 children, according to the United Nations. The outbreak, which has surpassed 4,000 cases and 1,850 deaths, is severely impacting healthcare access, with a significant drop in service usage due to fear of infection. The outbreak is particularly affecting pregnant women, with maternal deaths nearly doubling in the hardest-hit areas. The World Health Organization (WHO) is planning a clinical trial for the Ervebo vaccine to combat the virus, while community workers are actively engaged in spreading awareness and prevention measures.
Rapid Read Rapid Read
Ebola Outbreak in DRC Claims Over 300 Children's Lives, UNICEF Reports

Ebola Outbreak in DRC Claims Over 300 Children's Lives, UNICEF Reports

The Ebola outbreak in the Democratic Republic of Congo (DRC) has resulted in the deaths of over 300 children, according to UNICEF. Children represent nearly a quarter of confirmed cases and a third of all deaths. The outbreak, which has surpassed 4,000 cases with 1,850 deaths, is severely impacting healthcare access, with a 40% drop in service usage in affected areas. The World Health Organization (WHO) is advocating for a community-led response to improve early detection and care access. Efforts include deploying 13,000 community workers to educate the public on prevention and early detection.
Rapid Read Rapid Read
UPenn and WHO Collaborate on mRNA Technology to Combat Malaria in Low-Income Countries

UPenn and WHO Collaborate on mRNA Technology to Combat Malaria in Low-Income Countries

The University of Pennsylvania (UPenn) is collaborating with the World Health Organization (WHO) to expand mRNA technology for combating diseases like malaria in low and middle-income countries (LMICs). This initiative involves establishing Good Manufacturing Practice (GMP) sites in 15 LMICs, including regions in South America, Africa, and Southeast Asia. These sites are tasked with conducting research and development for vaccines and therapeutics targeting local diseases such as malaria, dengue, tuberculosis, and Zika. UPenn is also offering free licenses for its mRNA-LNP intellectual property to these countries. The collaboration aims to enhance the delivery and efficacy of mRNA-based treatments by utilizing AI-generated designs to improve RNA delivery and control immunogenicity.
Rapid Read Rapid Read
Ebola Outbreak in DRC Reaches Displacement Camps, Escalating Health Crisis

Ebola Outbreak in DRC Reaches Displacement Camps, Escalating Health Crisis

The Ebola outbreak in the Democratic Republic of the Congo (DRC) has spread to displacement camps in Ituri province, with 19 internally displaced people infected and five fatalities reported. The outbreak, which began in May, has resulted in nearly 4,000 cases and over 1,800 deaths. The World Health Organization (WHO) and other agencies are intensifying efforts to control the spread, including strengthening coordination with the DRC government and accelerating access to care. The outbreak is exacerbated by ongoing conflict in the region, which complicates response efforts and increases the risk of transmission.
Rapid Read Rapid Read
U.S. Bird Flu Risk Remains Low Despite New H9N2 Cases in China

U.S. Bird Flu Risk Remains Low Despite New H9N2 Cases in China

The World Health Organization has reported four new human infections of the H9N2 avian influenza in China, adding to a growing number of cases this year. Despite these developments, the Centers for Disease Control and Prevention (CDC) assesses the risk to the general U.S. public as low. The H9N2 virus, which is less pathogenic than H5N1, has been circulating in poultry across Asia and typically causes mild illness in humans. The CDC continues to monitor the situation, emphasizing that the risk is higher for individuals with direct exposure to infected poultry or dairy cattle.
Rapid Read Rapid Read
Moderna Launches First Human Trial for Bundibugyo Ebola Vaccine

Moderna Launches First Human Trial for Bundibugyo Ebola Vaccine

Moderna has initiated the first human clinical trial of its mRNA-1469 vaccine, designed to protect against the Bundibugyo strain of Ebola virus. This trial marks a significant step in addressing a strain of Ebola for which no approved vaccine currently exists. The Phase 1 trial will evaluate the vaccine's safety, side effects, and ability to elicit an immune response in approximately 84 healthy adults aged 18-65 in Canada. The vaccine uses Moderna's mRNA platform, previously successful in COVID-19 vaccine development, to target the Bundibugyo Ebola virus.
Rapid Read Rapid Read
WHO and Africa CDC Call for Urgent Action to Contain Ebola Outbreak in DRC

WHO and Africa CDC Call for Urgent Action to Contain Ebola Outbreak in DRC

The World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) have called for an urgent scale-up of efforts to contain the Ebola outbreak in the Democratic Republic of Congo (DRC). The outbreak, which has resulted in 4,053 confirmed cases and 1,850 deaths, is the second deadliest in history. WHO Director-General Tedros Adhanom Ghebreyesus and Africa CDC Director-General Jean Kaseya emphasized the need for early case identification, increased community involvement, and improved testing and treatment services. The WHO also recommended the Ervebo vaccine for a phase 3 clinical trial to assess its effectiveness against the Bundibugyo strain of the virus.